Literature DB >> 11844962

Expression of human beta defensin (HBD-1 and HBD-2) mRNA in nasal epithelia of adult cystic fibrosis patients, healthy individuals, and individuals with acute cold.

Nurlan Dauletbaev1, Roswitha Gropp, Michaela Frye, Stefan Loitsch, Thomas-Otto-Friedrich Wagner, Joachim Bargon.   

Abstract

BACKGROUND: Lack or inactivation of defensins may facilitate chronic bacterial colonization in the cystic fibrosis (CF) lung. CF nasal epithelium exhibits typical biochemical abnormalities and can be used to study defensin expression in CF.
OBJECTIVES: To evaluate the expression of beta defensin (HBD-1 and HBD-2) mRNA and the presence of inflammatory markers (percentage of neutrophils and IL-8 mRNA expression) in CF and non-CF nasal mucosa.
METHODS: Case-control study. Nasal brushing samples were obtained from 22 stable adult CF patients and 32 non-CF controls (25 healthy individuals and 7 individuals with acute cold). Samples were subjected to analysis involving mRNA expression (semiquantitative RT-PCR) and differential cell counting.
RESULTS: Defensins and inflammatory markers were expressed at low levels in healthy individuals and at high levels in subjects with acute cold. In non-CF controls, defensin expression correlated significantly with inflammatory parameters (p < 0.001). In CF, defensin mRNA expression was comparable to healthy individuals (p = 0.2). In contrast to non-CF controls, in CF patients high levels of inflammatory markers did not correlate with defensin mRNA levels.
CONCLUSIONS: Defensin expression is not upregulated in CF epithelium in response to inflammatory stimuli. Further studies are necessary to elucidate whether this is a consequence of the CF gene mutation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844962     DOI: 10.1159/000049369

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

1.  Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?

Authors:  Chee Y Ooi; Tamara Pang; Steven T Leach; Tamarah Katz; Andrew S Day; Adam Jaffe
Journal:  Dig Dis Sci       Date:  2015-08-14       Impact factor: 3.199

2.  Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps.

Authors:  Andrew P Lane; Quynh Ai Truong-Tran; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2006 Mar-Apr

3.  Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.

Authors:  Bruno Rivas-Santiago; Rogelio Hernandez-Pando; Claudia Carranza; Esmeralda Juarez; Juan Leon Contreras; Diana Aguilar-Leon; Martha Torres; Eduardo Sada
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

4.  Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis.

Authors:  Malte Book; QiXing Chen; Lutz E Lehmann; Sven Klaschik; Stefan Weber; Jens-Christian Schewe; Markus Luepertz; Andreas Hoeft; Frank Stuber
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 5.  Modulation of Human β-Defensin-1 Production by Viruses.

Authors:  Lisa Kathleen Ryan; Gill Diamond
Journal:  Viruses       Date:  2017-06-21       Impact factor: 5.048

Review 6.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 7.  Barrier function of airway tract epithelium.

Authors:  Shyamala Ganesan; Adam T Comstock; Uma S Sajjan
Journal:  Tissue Barriers       Date:  2013-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.